Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
MRD-status 1 jaar na stamceltransplantatie geassocieerd met overleving na 6 jaar
jun 2024 | MM, Stamceltransplantatie